Literature DB >> 25918077

Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.

Matej Skorvanek1, Jaroslav Rosenberger2, Michal Minar3, Milan Grofik4, Vladimir Han5, Johan W Groothoff6, Peter Valkovic7, Zuzana Gdovinova5, Jitse P van Dijk8.   

Abstract

The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is a newly developed comprehensive tool to assess Parkinson's disease (PD), which covers a wider range of non-motor PD manifestations than the original UPDRS scale. The aim of this study was to assess the relationship between the MDS-UPDRS and Quality of Life (QoL) and to analyze the relationship between individual MDS-UPDRS non-motor items and QoL. A total of 291 PD patients were examined in a multicenter Slovak study. Patients were assessed by the MDS-UPDRS, HY scale and PDQ39. Data were analyzed using the multiple regression analyses. The mean participant age was 68.0 ± 9.0 years, 53.5% were men, mean disease duration was 8.3 ± 5.3 years and mean HY was 2.7 ± 1.0. In a multiple regression analysis model the PDQ39 summary index was related to MDS-UPDRS parts II, I and IV respectively, but not to part III. Individual MDS-UPDRS non-motor items related to the PDQ39 summary index in the summary group and in the non-fluctuating patients subgroup were pain, fatigue and features of dopamine dysregulation syndrome (DDS). In the fluctuating PD patient subgroup, PDQ39 was related to pain and Depressed mood items. Other MDS-UPDRS non-motor items e.g. Anxious mood, Apathy, Cognitive impairment, Hallucinations and psychosis, Sleep problems, Daytime sleepiness and Urinary problems were related to some PDQ39 domains. The overall burden of NMS in PD is more important in terms of QoL than motor symptoms. Individual MDS-UPDRS non-motor items related to worse QoL are especially pain and other sensations, fatigue and features of DDS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine dysregulation syndrome; Fatigue; MDS–UPDRS; Non-motor symptoms; Pain; Quality of life

Mesh:

Substances:

Year:  2015        PMID: 25918077     DOI: 10.1016/j.jns.2015.04.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Personality and reported quality of life in Parkinson's disease.

Authors:  Gregory M Pontone; Zoltan Mari; Kate Perepezko; Howard D Weiss; Susan S Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

Review 2.  Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Authors:  Daniel Martinez-Ramirez; Michael S Okun; Michael S Jaffee
Journal:  Neurodegener Dis Manag       Date:  2016-07-13

3.  Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010).

Authors:  Cole D Stang; Aidan F Mullan; Emanuele Camerucci; Mania Hajeb; Pierpaolo Turcano; Peter Martin; Michelle M Mielke; Keith A Josephs; Matthew Splett; Victor Abler; Bradley F Boeve; James H Bower; Rodolfo Savica
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

4.  The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).

Authors:  Lu He; Eun-Young Lee; Nicholas W Sterling; Lan Kong; Mechelle M Lewis; Guangwei Du; Paul J Eslinger; Xuemei Huang
Journal:  J Parkinsons Dis       Date:  2016-05-31       Impact factor: 5.568

5.  Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.

Authors:  Jared T Hinkle; Kate Perepezko; Liana S Rosenthal; Kelly A Mills; Alexander Pantelyat; Zoltan Mari; Laura Tochen; Jee Yun Bang; Medha Gudavalli; Nadine Yoritomo; Ankur Butala; Catherine C Bakker; Vanessa Johnson; Emile Moukheiber; Ted M Dawson; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2017-11-21       Impact factor: 4.891

6.  Correlation Between the Movement Disorder Society's Unified Parkinson's Disease Rating Scale and Nonmotor Scales in Patients with Parkinson's Disease.

Authors:  Erika D Driver-Dunckley; Nan Zhang; Holly A Shill; Shyamal H Mehta; Christine M Belden; Edward Y Zamrini; Kathryn Davis; Thomas G Beach; Charles H Adler
Journal:  Innov Clin Neurosci       Date:  2019-09-01

7.  The Parkinson's Disease Sleep Scale-2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version.

Authors:  Pablo Martinez-Martin; John B Wetmore; Carmen Rodríguez-Blázquez; Tomoko Arakaki; Oscar Bernal; Victor Campos-Arillo; Christopher Cerda; Ingrid Estrada-Bellmann; Nélida Garretto; Letty Ginsburg; Jorge Uriel Máñez-Miró; Juan Carlos Martínez-Castrillo; Ivonne Pedroso; Marcos Serrano-Dueñas; Carlos Singer; Mayela Rodríguez-Violante; Francisco Vivancos
Journal:  Mov Disord Clin Pract       Date:  2019-03-18

8.  Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's Disease.

Authors:  Kristina Rosqvist; Per Odin; Stefan Lorenzl; Wassilios G Meissner; Bastiaan R Bloem; Joaquim J Ferreira; Richard Dodel; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2021-03-23

9.  Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease.

Authors:  Meredith A Bock; Ethan G Brown; Li Zhang; Caroline Tanner
Journal:  Neurology       Date:  2022-04-13       Impact factor: 11.800

10.  Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease.

Authors:  Márton Kovács; Attila Makkos; Zsuzsanna Aschermann; József Janszky; Sámuel Komoly; Rita Weintraut; Kázmér Karádi; Norbert Kovács
Journal:  Parkinsons Dis       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.